Moreover, exosomal miR-24-3p can be transferred from CAFs to colon cancer cells and down-regulate CDX2/HEPH axis, resulting in significantly enhanced resistance of colon cancer cells to methotrexate (MTX) (145). This evidence concerns the gene CDX2 and colonic neoplasm.